Lifengine Animal Health Laboratories Incorporated
- UEI
- N8JEWCR8XZL4
- CAGE
- 8AWY2
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Website
- leahlabs.com
- Founded
- 2018
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Mayo Clinic | R37CA266344 | $46,036 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Recombinetics Inc. | — | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Luminary Therapeutics, Inc. | Minneapolis, MN | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Gigamune, Inc. | San Francisco, CA | — |
| Creative Biotherapeutics LLC | Gurnee, IL | — |
| Cartesian Therapeutics Inc. | Frederick, MD | 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
About the company
Lifengine Animal Health Laboratories Incorporated is a for-profit corporate entity registered in SAM.gov, headquartered in Eagan, Minnesota. The company appears to specialize in advanced cellular engineering technologies, with a particular focus on developing innovative gene editing platforms and cell therapies for veterinary and human medical applications. Their proprietary GeneWeld gene editing technology enables precise cellular modifications, positioning them as a cutting-edge biotechnology research organization with significant capabilities in developing chimeric antigen receptor (CAR)-T cell therapies.
The company has received federal grant awards from multiple prestigious agencies, including the National Cancer Institute, National Science Foundation, and National Center for Advancing Translational Sciences. Their grant-funded research has concentrated on developing advanced CAR-T cell therapies for both veterinary and human oncology applications, with specific projects addressing challenges like cell therapy manufacturing scale, reducing cellular exhaustion, and creating virus-free precision gene-edited therapies. For instance, they received a $400,000 grant from the National Cancer Institute to develop CAR-T cells that can overcome functional exhaustion by overexpressing the C-MYB transcription factor, and a cooperative agreement with the National Science Foundation to develop clinical-scale cell therapy platforms for veterinary oncology. Additionally, they have participated in sub-awards, such as a collaboration with Mayo Clinic involving xenogeneic human CAR-T cell research using innovative imaging techniques to track cell expansion and trafficking in canine lymphoma models.
Quick answers
Is Lifengine Animal Health Laboratories Incorporated registered in SAM.gov?
Lifengine Animal Health Laboratories Incorporated's SAM.gov registration expired on September 3, 2026.
What is Lifengine Animal Health Laboratories Incorporated's most recent federal award?
Lifengine Animal Health Laboratories Incorporated's most recent federal grant award is C-MYB overexpression for exhaustion resistant car-t cell therapies (R43CA295178), from National Cancer Institute (NIH), on August 4, 2025.
On GovTribe
See Lifengine Animal Health Laboratories Incorporated's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors